P Sledzinski, M Nowaczyk, M Olejniczak - Cells, 2020 - mdpi.com
The CRISPR-Cas system has become a cutting-edge technology that revolutionized genome engineering. The use of Cas9 nuclease is currently the method of choice in most …
K Nakamura, H Kodera, T Akita, M Shiina… - The American Journal of …, 2013 - cell.com
Heterotrimeric G proteins, composed of α, β, and γ subunits, can transduce a variety of signals from seven-transmembrane-type receptors to intracellular effectors. By whole-exome …
H Moradian, T Roch, L Anthofer, A Lendlein… - … Therapy-Nucleic Acids, 2022 - cell.com
In vitro transcribed (IVT)-mRNA has been accepted as a promising therapeutic modality. Advances in facile and rapid production technologies make IVT-mRNA an appealing …
BC Guild, F DeRosa, M Heartlein - US Patent 9,308,281, 2016 - Google Patents
US9308281B2 - MRNA therapy for Fabry disease - Google Patents US9308281B2 - MRNA therapy for Fabry disease - Google Patents MRNA therapy for Fabry disease Download PDF …
Monocytes and macrophages are key players in maintaining immune homeostasis. Identifying strategies to manipulate their functions via gene delivery is thus of great interest …
A Higuchi, TC Sung, T Wang, QD Ling, SS Kumar… - Polymer …, 2023 - Taylor & Francis
Vaccine development is among the critical issues for ceasing the COVID-19 pandemic. This review discusses the current usage of biomaterials in vaccine development and provides …
P Sledzinski, M Dabrowska, M Nowaczyk… - Biotechnology …, 2021 - Elsevier
As the possibilities of CRISPR-Cas9 technology have been revealed, we have entered a new era of research aimed at increasing its specificity and safety. This stage of technology …
Efficiently delivering exogenous materials into primary neurons and neural stem cells (NSCs) has long been a challenge in neurobiology. Existing methods have struggled with …